Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307515 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
A Phase 3 study of Blood Loss, Surgical, sponsored by Ethicon.
- Completed
- Registry status
- Phase 3
- Development phase
- 135
- Enrollment target
- 16
- Study locations
NCT00307515: Completed Phase 3 study of Blood Loss, Surgical, sponsored by Ethicon.
NCT00307515 is a Phase 3 study of Blood Loss, Surgical that has completed, run by Ethicon. The registered enrollment target is 135 participants, above the 114-participant average among 6 other Blood Loss, Surgical trials with a reported enrollment target (18% higher). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00307515, a Phase 3 study of Blood Loss, Surgical, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 135 participants
- Enrollment target
- 16
- Study locations
Study Summary
A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
Conditions Studied
Interventions
- DRUG Fibrin Sealant 2 (FS2)
- DEVICE Oxidized Regenerated Cellulose (Surgicel)
Study Locations (16)
Pennsylvania
- Lehigh Valley Hospital - Allentown
- Children's Hospital of Pittsburgh - Pittsburgh
- Lankenau Hospital - Wynnewood
Florida
- Jacksonville Center for Clinical Research - Jacksonville
- Miami Research Associates - Miami
New York
- Mt. Sinai Hospital - New York
- GYN Oncology Associates - Syracuse
Texas
- MD Anderson Cancer Center - Houston
- The Methodist Hospital - Houston
California
- Children's Hospital of Los Angeles - Los Angeles
Georgia
- Medical College of Georgia - Augusta
Iowa
- The Iowa Clinic - Des Moines
Maryland
- St. Agnes Healthcare, Inc. - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00307515 record still lists
NCT00307515 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, above the 114-participant average among 6 other Blood Loss, Surgical trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Blood Loss, Surgical appearing as the primary indexed condition, and to 2 interventions - of which Fibrin Sealant 2 (FS2) is the first listed.
NCT00307515 lists 16 locations in 11 states (Pennsylvania, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT00307515 about?
NCT00307515 is a clinical study titled "Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery". A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
What is the current status of trial NCT00307515?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 135 participants. The study started on 2006-02. Estimated completion is 2006-12.
What conditions does trial NCT00307515 study?
This clinical trial studies the following conditions: Blood Loss, Surgical.
What interventions are being tested in trial NCT00307515?
The interventions under investigation include: Fibrin Sealant 2 (FS2) (DRUG), Oxidized Regenerated Cellulose (Surgicel) (DEVICE).
Who is sponsoring clinical trial NCT00307515?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00307515 being conducted?
This trial has 16 study locations across California, Florida, Georgia, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Loss, Surgical
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tranexamic Acid in Adult Spinal Deformity Surgery
RECRUITING · Phase 3
-
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
RECRUITING · Phase 4
-
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
RECRUITING · Phase 2
-
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
COMPLETED · Phase 4
-
Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery
COMPLETED · Phase 4
-
Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia